Stockscreener 앱 받기
0.4225
17.51%
-0.0897
시간 외 거래:
.41
-0.0125
-2.96%
전일 마감가:
$0.5122
열려 있는:
$0.4178
하루 거래량:
2.99M
Relative Volume:
0.34
시가총액:
$9.85M
수익:
-
순이익/손실:
$-14.93M
주가수익비율:
-0.00159
EPS:
-266.137
순현금흐름:
$-15.87M
1주 성능:
+0.17%
1개월 성능:
-7.79%
6개월 성능:
-97.47%
1년 성능:
-98.44%
1일 변동 폭
$0.41
$0.45
1주일 범위
$0.3866
$0.7867
52주 변동 폭
$0.2196
$66.33
트랜스코드 테라 Stock (RNAZ) Company Profile
명칭
Transcode Therapeutics Inc
전화
857-301-6857
주소
6 LIBERTY SQUARE, BOSTON
RNAZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
0.4225 | 9.85M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
트랜스코드 테라 주식(RNAZ)의 최신 뉴스
TransCode Plans Massive 28:1 Stock Consolidation: What This Means for Your RNAZ Shares - Stock Titan
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga
Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday - Benzinga
TransCode Therapeutics (RNAZ) Plans 1-for-28 Reverse Stock Split - GuruFocus
Offerings News Live Feed - Stock Titan
TransCode Therapeutics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa
TransCode Therapeutics (RNAZ) Announces 1-for-28 Reverse Stock Split - GuruFocus
TransCode Therapeutics approves reverse stock split to meet Nasdaq rules - Investing.com
TransCode Therapeutics approves 1-for-28 reverse stock split; shares fall - MSN
TransCode Therapeutics to Implement 1-for-28 Reverse Stock Split - marketscreener.com
TransCode Plans Major 1:28 Reverse Split, Slashing Shares from 23M to 833K for Nasdaq Listing - Stock Titan
For Dropbox Inc [DBX], Analyst sees a drop to $30. What next? - dbtnews.com
Direct Digital Holdings Inc [DRCT] is -44.37% lower this YTD. Is it still time to buy? - dbtnews.com
CN Energy Group Inc [CNEY] Is Currently 9.75 above its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
Wall Street Analyst Upgrade Rush Street Interactive Inc [RSI]. What else is Wall St. saying - dbtnews.com
why Kronos Bio Inc [KRON] is a Good Choice for Investors After New Price Target of $1.00 - dbtnews.com
Glaukos Corporation [GKOS] Revenue clocked in at $383.48 million, down -44.28% YTD: What’s Next? - dbtnews.com
Republic Digital Acquisition Company [RDAGU] Stock trading around $10.15 per share: What’s Next? - dbtnews.com
Venture Global Inc [VG] stock Initiated by UBS analyst, price target now $14 - dbtnews.com
Hayward Holdings Inc [HAYW] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
Market cap of Solaris Energy Infrastructure Inc [SEI] reaches 1.55B – now what? - dbtnews.com
why Astera Labs Inc [ALAB] is a Good Choice for Investors After New Price Target of $111.21 - dbtnews.com
TransCode Stock Rallies On Promising Metastatic Cancer Drug Trial: Retail Sees More Upside - Asianet Newsable
IBN Coverage: TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138 - Yahoo Finance
TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138 - The Globe and Mail
TransCode's Cancer Drug Achieves Major Safety Milestone: 13 Patients Show No Toxicity in Latest Trial Data - Stock Titan
EXCLUSIVE: TransCode Therapeutics Reports Progress In Early-Stage Study For Lead Cancer Drug - Benzinga
Selling Your TransCode Therapeutics Inc (NASDAQ: RNAZ) Stock? Here’s What You Need To Know - Stocksregister
TransCode Therapeutics (RNAZ) Adjourns Special Meeting to May 2 - GuruFocus
TransCode Therapeutics Inc (RNAZ) can make a big difference with a little luck - Sete News
Does Arbe Robotics Ltd (ARBE) offer a good opportunity for investors? - Sete News
A Look at Murphy Oil Corp (MUR) Shares in the Recent Past Indicates Growth - Sete News
TransCode Therapeutics Inc (RNAZ) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
TransCode Therapeutics stock slides after announces to raise $10M securities offering - MSN
TransCode Therapeutics Inc (RNAZ) deserves closer scrutiny - uspostnews.com
Short Interest in TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Decreases By 59.2% - Defense World
(RNAZ) Trading Signals - news.stocktradersdaily.com
What’s The Deal With TransCode Therapeutics Inc (NASDAQ: RNAZ)? - Stocksregister
TransCode Therapeutics Faces Crucial Reverse Split Decision as Special Meeting Falls Short of Quorum - Stock Titan
TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting - Yahoo Finance
What is the investor’s view on TransCode Therapeutics Inc (RNAZ)? - uspostnews.com
HC Wainwright Issues Pessimistic Forecast for RNAZ Earnings - The AM Reporter
All You Need to Know About TransCode Therapeutics (RNAZ) Rating Upgrade to Buy - NewsBreak: Local News & Alerts
HC Wainwright Cuts TransCode Therapeutics (NASDAQ:RNAZ) Price Target to $10.00 - Defense World
Research Analysts Offer Predictions for RNAZ Q1 Earnings - Defense World
Transcode Therapeutics stock hits 52-week low at $0.34 By Investing.com - Investing.com South Africa
Transcode Therapeutics stock hits 52-week low at $0.34 - Investing.com
An Open Letter to Shareholders of TransCode Therapeutics, Inc. Asking Stockholders to Vote FOR the Proposal to Authorize a Reverse Stock Split if Necessary - Yahoo Finance
TransCode Therapeutics Inc: Weathering Stock Market Storms with 8.59M Market Cap - investchronicle.com
Transcode Therapeutics, Inc. SEC 10-K Report - TradingView
TransCode Therapeutics Inc (NASDAQ: RNAZ) Stock: Bulls Should Watch This - stocksregister.com
트랜스코드 테라 (RNAZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):